Recent federal Practice Guidelines from SAMHSA have allowed for an alternative Notice of Intent to Prescribe (NOI) for those seeking to treat up to 30 patients. The customary NOI requires eligible providers to undertake required training activities prior to their application to prescribe Buprenorphine; the alternative type of NOI allows those providers who wish to treat up to 30 patients to forego the training requirement, as well as certification to counseling and other ancillary services (i.e., psychosocial services). Practitioners utilizing this training exemption are limited to treating no more than 30 patients at any one time (time spent practicing under this exemption will not qualify the practitioner for a higher patient limit). This exemption applies only to the prescription of Schedule III, IV, and V drugs or combinations of such drugs, covered under the CSA, such as buprenorphine.